Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Sep 06, 2017 2:10pm
80 Views
Post# 26662437

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:In a blink of an eye, TLT suits very well OPKO urology div.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:In a blink of an eye, TLT suits very well OPKO urology div.
bionicjoe wrote:
Oilminerdeluxe wrote: I still wonder why Bj hasn't been suspended


For what, trying to bring some common sense to this board?





JOE


Share your common sense please

Since you seem so knowledgable joe, what catalyst or situation do you see tlt derisking and able to raise market cap on the current exchange it sits, or which catalyst do you see that will allow upgrade then movement? What financing do you see upcoming? If all is successful in the science, do you feel we are 6 months away or two years?
Bullboard Posts